Please assess the completion status of the following clinical trial:

Trial Title: Reducing Anxiety and Stress in Primary Care Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 years or older~* Veteran seen in the Syracuse VA Medical Center primary care clinic in the past year~* Screen positive for current (past 2 weeks) clinically significant anxiety symptoms (8 on Generalized Anxiety Disorder-7)~Exclusion Criteria:~* Inability to communicate in English (as assessed by study staff)~* Report or demonstrate hearing impairment that would preclude telephone screening (as assessed by study staff)~* Inability to demonstrate informed consent~  * defined as not being able to comprehend the study description as assessed by study staff and/or not being able to answer the comprehension of consent questions~ * have a diagnosis of dementia or severe cognitive impairment (defined by primary care provider or self-report, or having a diagnosis in Problem List)~ * screen positive for cognitive impairment (3 or more errors on cognitive screener)~* Have a diagnosis of obsessive-compulsive disorder (OCD) or serious mental illness (SMI) in Problem List~  * i.e., psychotic disorders, bipolar disorder~* Have an encounter diagnosis of post-traumatic stress disorder (PTSD) within the past 2 years OR screen positive for PTSD (3 or more on PC-PTSD-5)~* Currently in psychotherapy/counseling for anxiety and/or depression, defined as any of the following within the past 30 days:~  * attending specialty mental health sessions \[excluding a single intake session\]~ * attending 2 or more Primary Care-Mental Health Integration sessions~ * Being hospitalized for mental health treatment~* Report severe depressive symptoms (20 or more on Patient Health Questionnaire-9)~* At imminent risk of suicide~  * defined as being identified as imminent risk based on study staff's suicide risk assessment \[verified by the PI\] and in need of intensive treatment~ * e.g., hospitalization\] to ensure safety~* Started or had dosage change in psychotropic medication for anxiety or depression in the past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Brief anxiety intervention (Type: EXPERIMENTAL): Modular anxiety intervention designed for PC-MHI, up to six 30-minute sessions occurring approximately every 2 weeks, patients select modules of interest to them to complete, emphasis on psycho-education and cognitive-behavioral coping strategies for self-management
- Usual PC-MHI care (Type: ACTIVE_COMPARATOR): Appointment with PC-MHI provider at local primary care clinic, providers delivers whatever interventions they deem appropriate and collaboratively decides with patients whether and when to meet again as in routine PC-MHI care

Based on this trial design, predict the completion outcome and termination type (if applicable).